Miral and SeaWorld Entertainment, Inc. (NYSE:SEAS) (“SeaWorld”) today announced their partnership to develop SeaWorld Abu Dhabi, a first-of-its-kind marine life themed park on Yas Island. This next generation SeaWorld Abu Dhabi will also include the United Arab Emirates’ (“UAE”) first dedicated marine life research, rescue, rehabilitation and return center with world-class facilities and resources for the care and conservation of local marine life. SeaWorld Abu Dhabi will be the first new SeaWorld without orcas, and will integrate up-close animal experiences, mega attractions and a world class aquarium, bringing the latest technology in visitor engagement.
The partnership brings together Miral’s expertise in developing Yas Island’s portfolio of destinations with SeaWorld’s 50-plus years of theme park, veterinary medicine, marine science and zoological practice and experience.
To view the multimedia release go to:
http://www.multivu.com/players/uk/8002251-miral-announces-seaworld-yas-island/
Raytheon Company (NYSE: RTN) unveiled its second generation Exoskeleton (XOS 2) at its research facility in Salt Lake City, Utah, during a demonstration with Paramount Home Entertainment. The new robotic suit is lighter, faster and stronger than its predecessor, yet it uses 50 percent less power. Its enhanced design also means that it is more resistant to the environment.
To view Multimedia NewsRelease, go to http://multivu.prnewswire.com/mnr/raytheon/46273/
VolAero Drones is working with famed outdoorsman Bill Booth to demonstrate that drones equipped with the latest thermal imaging equipment can effectively spot and track pythons at night – the prime hunting time. Over 100,000 Burmese pythons infesting the Florida Everglades have decimated 90 percent of small wildlife while surviving all attempts at eradication.
“Python hunters finally have a tool to make hunting more efficient, bringing down the python numbers that are devastating Florida’s Everglades,” said Booth. “This drone and thermal technology is light-years ahead of shining a flashlight into the darkness and hoping for the best. The thermal imagery picked up not just the monster pythons, but also native snakes as small as 18 inches. This suggests that we’ll be able to spot and eliminate clusters of python hatchlings, which will help curb their reproductive cycle.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8225051-volaero-drones-thermal-technology-python-invasion-everglades/
Featuring a noted cancer researcher, animal behaviorists and a 14-year-old entrepreneur who developed a new product to ease pets’ separation anxiety, Purina’s second Better With Pets Summit emphasized how technology and scientific advances are leading to a brighter future with our pets. The daylong event, Tuesday, in New York City featured 15 expert presentations on scientific, nutritional and behavioral innovations to help better understand why our lives are better with pets.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7325551-purina-better-with-pets-summit-2014/
The Yankee Candle Company, Inc., the world’s largest manufacturer of premium scented candles, today announced the launch of the new Pure Radiance™ Crackling LumiWick™, featuring natural wood with our exclusive Lumiwick™ to create an extra-wide crackling flame with a soft, radiant glow. When lit, this new candle form creates a unique home experience for friends and family with an ambient crackling wood fire experience. The Crackling LumiWick™ with etched bark glass, will be available in three Pure Radiance™ fragrances this holiday season. Pure Radiance™, launched earlier this year, has a modern design, custom soy wax blend and innovative LumiWick™ technology for a wide flame and consistent burn. The new holiday fragrances are available for purchase now at Yankee Candle’s more than 550 retail stores, www.yankeecandle.com and select specialty retailers and gift shops.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56813-yankee-candle-pure-radiance-crackling-lumiwick
Procter & Gamble’s (NYSE: PG) PUR Water Filtration is introducing a new line-up of one-click faucet mount filtration systems that makes getting clean drinking water instantly from the tap easier and more convenient than ever before. The first and only faucet mount design that installs with one easy click, the new PUR faucet water filter offers up to 100 gallons of great-tasting drinking water with just one click. The new design is simple to install so that no tools are required and it can be easily disconnected when needed.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/pur/45502/
PUMA kicked off its 2014 Nature of Believing campaign, with the launch of the revolutionary new evoPOWER football boot at a live event in Barcelona last Friday. PUMA Power players Cesc Fàbregas, Marco Reus and Mario Balotelli put their football skills to the test on the evoPOWER wall, the custom built football simulator that utilises Hawk Eye technology to measure players’ power and accuracy. evoPOWER was inspired by the freedom of movement of a bare foot – Fàbregas, Reus and Balotelli showcased their skills and the boots performance enhancing technology through four interactive challenges.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64184-puma-launches-evopower-football-event
St. Jude Children’s Research Hospital® officials and guests today marked the opening of the St. Jude Red Frog Events Proton Therapy Center, the first proton therapy center in the world dedicated solely to children with cancer.
Patients are now being treated at the center using precisely delivered, high-energy particles called protons to kill or shrink tumors while minimizing damage to healthy tissue and organs. For patients with brain tumors and certain other cancers, research suggests proton beam therapy may be more effective than conventional radiation at preventing the growth and spread of tumors while reducing the risk of treatment-related side effects.
To view the multimedia release go to:
http://www.multivu.com/players/English/7713451-st-jude-proton-therapy-opening/
Solta Medical, Inc. (Nasdaq: SLTM), a global leader in the medical aesthetics market and manufacturer of the industry's three premier brands: Thermage®, Fraxel®, and Isolaz®, is pleased to announce that it has partnered with PGA TOUR golfer Scott McCarron to raise awareness about skin protection and the Fraxel re:store® laser treatment. As the leader in fractional laser technology, Fraxel delivers minimally invasive clinical solutions to resurface aging and sun damaged skin, including the removal of actinic keratoses (AK’s ) — a precancerous skin condition caused by sun exposure. Fraxel re:store treatment provides superior results for AKs on the face or other areas of the body displaying the signs of photodamage.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/solta/45388/
EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, announced today that new 10 year data from an international registry-based multi-center study shows 83 percent of patients had no biopsy evidence of disease after treatment with Ablatherm® HIFU, supporting the technology as a standard primary treatment for localized prostate cancer. Study results were presented at the American Urological Association (AUA) 2011 Annual Meeting, Washington, D.C.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/edap/49862/
More tactile than the originals it emulates, and even easier to use, ReBirth has just been released by Propellerhead for the Apple iPad. Propellerhead ReBirth for iPad fuses great sounding music machines with a can't-miss, hands-on interface for the ideal music creation system ready for the couch, bus, club or Internet post.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/propellerheadsoftware/46310/
Boston Scientific Corporation (NYSE:BSX) announces U.S. Food and Drug Administration (FDA) approval for the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System, the Company’s next-generation drug-eluting stent (DES) technology. The PROMUS Element Stent, designed to provide physicians improved DES performance in treating patients with coronary artery disease, is built on an innovative platinum chromium (PtCr) platform with the market-leading everolimus drug. The Company plans to begin marketing the product in the U.S. immediately.
To view Multimedia News Release, go to http://www.multivu.com/mnr/43510-boston-scientific-fda-promus-element-plus-platinum-chromium-stent-system
